The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 01, 2015
Filed:
Feb. 14, 2012
Applicants:
Stephen W. Byers, Takoma Park, MD (US);
Sivanesan Dakshanamurthy, Herndon, VA (US);
Ziad Sahab, Fairfax, VA (US);
Inventors:
Stephen W. Byers, Takoma Park, MD (US);
Sivanesan Dakshanamurthy, Herndon, VA (US);
Ziad Sahab, Fairfax, VA (US);
Assignee:
Georgetown University, Washington, DC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 233/65 (2006.01); A61K 31/166 (2006.01); C07C 235/84 (2006.01); C07D 213/56 (2006.01); C07D 233/90 (2006.01); C07D 307/68 (2006.01); C07D 417/12 (2006.01); C07C 233/75 (2006.01); C07C 237/12 (2006.01); A61K 31/196 (2006.01); A61K 31/341 (2006.01); A61K 31/357 (2006.01); A61K 31/4155 (2006.01); A61K 31/4178 (2006.01); A61K 31/4406 (2006.01); A61K 31/4436 (2006.01); A61K 38/05 (2006.01); A61K 45/06 (2006.01); C07D 307/66 (2006.01); C07D 317/46 (2006.01); C07D 403/04 (2006.01); C07D 409/14 (2006.01); C07K 5/065 (2006.01);
U.S. Cl.
CPC ...
C07C 235/84 (2013.01); A61K 31/196 (2013.01); A61K 31/341 (2013.01); A61K 31/357 (2013.01); A61K 31/4155 (2013.01); A61K 31/4178 (2013.01); A61K 31/4406 (2013.01); A61K 31/4436 (2013.01); A61K 38/05 (2013.01); A61K 45/06 (2013.01); C07C 233/65 (2013.01); C07C 233/75 (2013.01); C07C 237/12 (2013.01); C07D 213/56 (2013.01); C07D 233/90 (2013.01); C07D 307/66 (2013.01); C07D 307/68 (2013.01); C07D 317/46 (2013.01); C07D 403/04 (2013.01); C07D 409/14 (2013.01); C07D 417/12 (2013.01); C07K 5/06078 (2013.01);
Abstract
Small molecule inhibitors of AGBL2 are provided, as well as methods of using the inhibitors to treat or prevent cancer and neurologic disorders.